Research & Development: Page 43
-
PharmaVoice Team/PharmaVoice
Pharma Innovation Labs
Innovative or collaborative partnerships in pharma are being touted by some as the “new normal." Certainly, this is true of several pioneering pharmaceutical companies in the space, but authentic, independent or open-source collaborations are still a minority in the life-sciences ecosystem. The b...
By Robin Robinson • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Next-Generation Nanomedicines
The first generation of nanotechnology-based medicines, including nano-based drug delivery systems and nanovectors, improved the safe delivery of therapies that were once toxic. Nanoparticles have also proven to be especially good vehicles to effectively deliver cancer drugs, where many therapies...
By Denise Myshko • Jan. 1, 2018 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Women's Healthcare: Drug Development
With a U.S. healthcare market estimated at $2.8 trillion and purchasing either made or largely influenced by women, the “power of the purse" has never been stronger. According to Carolyn Buck Luce, executive-in-residence at the Center for Talent Innovation and an adjunct professor at Columbia Uni...
By Taren Grom • Jan. 1, 2018 -
PharmaVoice Team/PharmaVoice
Trend Tracking
In this special — 2018 Year in Preview — issue, PharmaVOICE’s thought leaders are tackling 10 trends that are expected to incite change in the year ahead. We will be looking at a variety of disparate topics that range from molecule to market in keeping with our publishing focus and philosophy: 20...
By Taren Grom • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Trending 2018: Real-World Outcomes
Real-word outcomes is not a new trend by any means, but it’s a market-changing model that is coming into its own and worthy of covering. That’s because the pharmaceutical market continues to shift to an outcomes-based reimbursement system, driven by payers’ need to rein in rising drug prices, adv...
By Denise Myshko • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Picture This: Managing the Entire Lifecycle of Clinical Trial Images in a Single Tool
One of the great promises of technology is that it can simplify our lives. The need for it to do so is particularly strong in clinical research, where trials have been growing ever more complex. This is due, in part, to regulators’ increasing requests for the inclusion of imaging analysis when ev...
By Tim Kulbago • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Speak Out
Innovations in Alzheimer’s Clinical Trial Design Promise to Reduce Time, Risk by Allison House, Therapeutic Strategy Lead, Neuroscience, Worldwide Clinical Trials and Natalia Drosopoulou, Senior Director, Global Project Management, Neuroscience, Worldwide Clinical Trials The global impact of Alz...
By Allison House • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Red Zone: Innovation in Hematopoietic Cell Transplantation and Gene and Cellular Therapies Drive Results in Pediatric Oncology
This is an exciting time in medicine, providing more novel treatments for patients with cancer blood disorders. Scientists are learning more about the human genome and its role in disease. This knowledge allows investigators to develop new diagnostic tools and therapeutic interventions to more sp...
By Medpace • Nov. 20, 2017 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Connected Health At this month’s 2017 Connected Health Conference to be held in Boston, industry leaders will gather to discuss a multitude of topics that are focused on improving health outcomes by accelerating the adoption of personal connected health. A couple of the major themes to be discuss...
By Taren Grom • Oct. 1, 2017 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Using Electric Fields to Treat Cancer Bill Doyle, Executive Chairman of Novocure, talks about the company’s treatment that uses electric fields to treat glioblastoma, a deadly brain cancer, and other cancers. Novocure’s approach to treating cancer may look like pseudo science, but the results are...
By Bill Doyle • Oct. 1, 2017 -
PharmaVoice Team/PharmaVoice
Last Word
Pharma’s Role in the Community John Damonti, President of the Bristol-Myers Squibb Foundation and VP of Corporate Philanthropy at Bristol-Myers Squibb, talks about how his company and other pharmaceutical companies can provide relief during disasters, such as Hurricanes Harvey and Irma. PV: Why d...
By John Damonti • Oct. 1, 2017 -
PharmaVoice Team/PharmaVoice
A Connected Healthcare Life
Three years ago, Verily — then a division of Google X — unveiled its Baseline Project, a collaboration with Duke University and Stanford University to collect health data from healthy people to get a sense of what “normal" looks like. Earlier this year, the group began the process of enrolling 10...
By Robin Robinson • Oct. 1, 2017 -
PharmaVoice Team/PharmaVoice
Solutions for Clinical Sites
Clinical study sites are transforming their technology infrastructures with the adoption of electronic medical records (EMRs). But while EMRs improve treatment-related tasks in healthcare settings, they have not helped to reduce the burden of clinical trial studies on the sites. A May 2017 survey...
By Denise Myshko • Oct. 1, 2017 -
PharmaVoice Team/PharmaVoice
Upfront
Bayer and the White Ribbon Alliance The partnership of Bayer and the White Ribbon Alliance (WRA), Every Woman Every Child, has reached 1,200 women in 91 communities across four developing countries. The partnership’s goal has been to launch local community programs to support the reduction and pr...
By PharmaVoice Team • Sept. 1, 2017 -
PharmaVoice Team/PharmaVoice
HealthTech
New Exhaled Breath Sensor Spots Diseases, Monitors Health Trend Watch: The application of very small things to yield very big health results A study published in the Accounts of Chemical Research journal reports that Korea Advanced Institute of Science and Technology’s researchers have developed ...
By PharmaVoice Team • Sept. 1, 2017 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
A New Option for PAH Preston Klassen, M.D., Executive VP, Research and Development and Chief Medical Officer, Arena Pharmaceuticals, talks about the company’s efforts to develop a new therapy for pulmonary hypertension. Pulmonary arterial hypertension (PAH) is a rare disease that affects the hear...
By Preston Klassen • Sept. 1, 2017 -
PharmaVoice Team/PharmaVoice
Speak Out
TREATING THE WHOLE PATIENT: A More Compelling Approach to Product Development Instead of focusing only on your product, consider the impact if your product was studied in tandem with an intervention that addresses whole patient needs. By taking this approach, you’re formulating a plan to differen...
By Mark Matthews • Sept. 1, 2017 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Storied Careers This is my favorite issue of the year — nothing against the other great issues we put out every month. But there is something particularly special about showcasing 100 men and women who have dedicated their lives to the life-sciences industry. They could be using their talents in ...
By Taren Grom • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
Who's On The List by Section
This article contains the list of 100 honorees. If you want to read the article featuring a particular person, please view the Section in which he/she is featured. Change Agents Danielle Bedard inVentiv Health Kathy Biberstein Alkermes Kim Carpenter HCB Health Dr. Ryan Cohlhepp Takeda Oncology Su...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Clinical Experts
Mark Penniston The Curious Pragmatist Title: Executive VP and General Manager, Clinical Analytics & Source Company: Chiltern Education: BS, MS, University of Massachusetts Family: Wife, Melissa Hobbies: Reading, traveling to National Parks & Disney Social Media: In this biotech environmen...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Innovators
Dr. Bill Byrom At the Forefront of eClinical Technology Title: Senior Director of Product Innovation Company: ICON Clinical Research Education: BSc, Mathematics with Statistics, University of Nottingham; PhD, University of Strathclyde Family: Wife, Tina; two teenage daughters, Charlotte and Sophi...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Patient Advocates
Nikki Levy Caring Connections Title: VP, Patient Engagement Company: Alkermes Inc. Education: BS, Communications, Illinois State University Family: As a child of a single mom she learned to be fiercely independent, internally motivated and to value hard work Hobbies: Running, reading, traveling A...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Researchers & Scientists
Dr. Daniel Auclair Bridging the Cancer Gaps Title: Senior VP, Research Company: Multiple Myeloma Research Foundation Education: BS, Biochemistry, MSc, Biochemistry, University of Montreal; PhD, Nutrition/Biochemistry, Dana-Farber Cancer Institute/Harvard Cancer Center Family: Father — lost to an ...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
The Technologists
Steve Powell Tackling Technology Innovation with a Patient-Focus Title: Executive VP of Trial Oversight Company: ERT Education: BSc (Hons), Mathematics, University of Wales, Cardiff Family: Lori, his wife who supports him in the career decisions and the changes he makes; Betty and Eddie, his mot...
By PharmaVoice Team • Aug. 1, 2017 -
PharmaVoice Team/PharmaVoice
Red Jacket Awards
2017 Red Jacket Honorees PharmaVOICE introduced the Red Jacket Award in 2014 to celebrate the 10th anniversary of the PharmaVOICE 100. One of the criteria for being named a Red Jacket — our version of a Hall of Fame — is having been recognized previously as a PharmaVOICE 100 honoree, but it’s muc...
By PharmaVoice Team • Aug. 1, 2017
Previous
